Growth regulation of human glioblastoma t98g cells by insulin‐like growth factor‐1 and its receptor

The interaction of insulin‐like growth factors (IGFs) with the IGF‐1 receptor is an important step in the control of cell proliferation and development. In particular, IGF‐1 and IGF‐2 are key regulators of central nervous system development, and may modulate the growth of glial tumors. We have investigated the growth factor regulation of the human glioblastoma cell line T98G. These cells growth arrested in serum‐free medium at 34°C, despite their secretion of substantial amounts of bioactive IGF‐1. To be stimulated to divide, growth‐arrested cells required the addition of platelet‐derived growth factor (PDGF) or its equivalent, 1% serum. Cell proliferation in serum‐free medium could also be obtained by shifting the cells to a temperature of 39.6°C. Treatment of growth‐arrested cells with PDGF or temperature shift was accompanied by a transient increase in the expression of the mRNA for the IGF‐1 receptor. Transfection with a plasmid constitutively expressing the full cDNA for the human IGF‐1 receptor allowed autonomous growth in serum‐free medium at 34°C. By contrast, growth induction by growth factors or temperature shift was abrogated by transfection of the cells with a plasmid expressing a 300 bp segment of mRNA antisense to the IGF‐1 receptor mRNA. Cloning in soft agar was also inhibited by expression of antisense IGF‐1 receptor mRNA. These results demonstrate that the IGF‐1 receptor is strictly required for the growth of T98G glioblastoma cells. Moreover, the autocrine interaction of IGF‐1 with its receptor regulates both autonomous and anchorage‐independent growth of these cells. © 1994 wiley‐Liss, Inc.

[1]  E. Kawashima,et al.  Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[3]  W. Mercer,et al.  Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency , 1982, Molecular and cellular biology.

[4]  D. Clemmons,et al.  Insulin‐like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs) , 1990, Journal of cellular physiology.

[5]  A. Ullrich,et al.  Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes. , 1988, Oncogene research.

[6]  R. Baserga The double life of the IGF-1 receptor. , 1992, Receptor.

[7]  C. Heldin,et al.  Synthesis of a PDGF-like growth factor in human glioma and sarcoma cells suggests the expression of the cellular homologue to the transforming protein of simian sarcoma virus. , 1983, Biochemical and biophysical research communications.

[8]  C. Stiles,et al.  Dual control of cell growth by somatomedins and platelet-derived growth factor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[10]  C. Osborne,et al.  Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. , 1989, Cancer research.

[11]  R. Glick,et al.  Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. , 1989, Neurosurgery.

[12]  S. Gammeltoft,et al.  Expression of two types of receptor for insulin-like growth factors in human malignant glioma. , 1988, Cancer research.

[13]  R. Knight,et al.  IGF-II mRNA expression in LI human glioblastoma cell line parallels cell growth , 1992, Neuroscience Letters.

[14]  M. Tykocinski,et al.  Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. , 1993, Science.

[15]  P. Thomas,et al.  Hybridization of denatured RNA transferred or dotted nitrocellulose paper. , 1983, Methods in enzymology.

[16]  R. Baserga,et al.  The role of the IGF‐1 receptor in the stimulation of cells by short pulses of growth factors , 1993, Cell proliferation.

[17]  J. Minna,et al.  Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. , 1988, The Journal of clinical investigation.

[18]  E. Craig,et al.  Sequence organization of two recombinant plasmids containing genes for the major heat shock-induced protein of D. melanogaster , 1979, Cell.

[19]  G. Stein,et al.  Involvement of the 5'-leader sequence in coupling the stability of a human H3 histone mRNA with DNA replication. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Werner,et al.  13 – Insulin-Like Growth Factors in the Brain , 1993 .

[21]  D. Clemmons,et al.  Variables controlling somatomedin production by cultured human fibroblasts , 1983, Journal of cellular physiology.

[22]  P. Black,et al.  Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. , 1990, The Journal of clinical investigation.

[23]  A. Ferber,et al.  The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism. , 1991, Cancer research.

[24]  V. Macaulay,et al.  Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.

[25]  W. Russell,et al.  Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Antoniades,et al.  Expression of insulin‐like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry , 1992, International journal of cancer.

[27]  M. Merrill,et al.  Insulin-like growth factor-I receptors in human glial tumors. , 1990, The Journal of clinical endocrinology and metabolism.

[28]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[29]  S. Chernausek Insulin‐like growth factor‐I (IGF‐I) production by astroglial cells: Regulation and importance for epidermal growth factor‐induced cell replication , 1993, Journal of neuroscience research.

[30]  C. Heldin,et al.  Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. , 1991, The Journal of biological chemistry.

[31]  W. Sly,et al.  Insulin-like growth factor receptor expression and function in human breast cancer. , 1990, Cancer research.

[32]  G. Stein T98G: An anchorage‐independent human tumor cell line that exhibits stationary phase G1 arrest in vitro , 1979, Journal of cellular physiology.

[33]  S. Jacobs,et al.  An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. , 1987, Biochemical and biophysical research communications.

[34]  C. Roberts,et al.  Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). , 1993, The Journal of biological chemistry.

[35]  D. Coppola,et al.  Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[36]  P. Porcu,et al.  Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. , 1992, Cancer research.

[37]  T. Meyer,et al.  Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. , 1992, Endocrinology.

[38]  K. Hall,et al.  Insulin-like growth factors and their binding proteins. , 1990, Physiological reviews.

[39]  M. Tykocinski,et al.  Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W. Richardson,et al.  A role for platelet-derived growth factor in normal gliogenesis in the central nervous system , 1988, Cell.